Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models

  1. Bargiela, A.
  2. Sabater-Arcis, M.
  3. Espinosa-Espinosa, J.
  4. Zulaica, M.
  5. De Munain, A.L.
  6. Artero, R.
Revue:
Proceedings of the National Academy of Sciences of the United States of America

ISSN: 1091-6490,  0027-8424

Année de publication: 2019

Volumen: 116

Número: 50

Pages: 25203-25213

Type: Article

DOI: 10.1073/PNAS.1820297116 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus